Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Indian Journal of Pathology: Research and Practice

Volume  8, Issue 5, September - October 2019, Pages 686-689
 

Original Article

Comparative Study of Prothrombin Time, Activated Partial Thromboplastin Time and Platelet Counts in Type II Diabetes Mellitus and Healthy Individual

Hemaxi Patel1, Toral Jivani2, Purvi Patel3

12nd Year Resident, 2Assistant Professor, 3Tutor, Department of Pathology, Surat Municipal Institute of Medical Education & Research, Surat, Gujarat

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: DOI: http://dx.doi.org/10.21088/ijprp.2278.148X.8519.26

Abstract

Background: In diabetic patients incidence of cardiovascular disease due to thrombosis is higher than healthy individual. PT, aPTT and Platelet count are haematological parameters that give an idea about the coagulation status. So, this study aimed to assess the prothrombin time, activated partial thromboplastin time and platelet counts of type II diabetes mellitus patients. Methods: A comparative study was conducted at SMIMER hospital, Surat. A total 50 type II diabetic patients and 50 healthy control were included in this study. 4 ml of blood was collected in citrate bulb to determined PT, aPTT and Platelet count of these 2 Groups. Results: The mean aPTT of diabetic and healthy control 25.14 ± 6.32 and 35 ± 3.23 s, respectively. The proportion of diabetic patients with normal PT, aPTTand platelet counts was 84.0%, 10% and 92.0%, respectively. There was significant shortening of aPTT in Type II diabetic patients. Conclusions: There was a significant shortening of aPTT in diabetic patients as compared with non-diabetic groups. So, shortening of aPTT in untreated Type II diabetic patients might be useful marker in patients with diabetes and monitoring of the aPTT in newly diagnosed diabetic patients is important to prevent hypercoagulation.

Keywords: Activated partial thromboplastin time; Platelet count; Prothrombin time; Type II Diabetes mellitus; SMIMER hospital Surat.


Corresponding Author : Toral Jivani